Concepedia

Sergio Borgia

SB

23

Publications

1.7K

Citations

16

H-Index

1993

Active since

Affiliations

William Osler Health System(Current)

University of Alberta

University of Toronto

Gilead Sciences (United States)

University of Calgary

Sergio Borgia is an author at William Osler Health System specializing in medicine, infection control, and emergency medicine.

ORCID

Top concepts

Publications per year

1993–2022

23

Publications

23

Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes

Sergio Borgia, Charlotte Hedskog, Bandita Parhy et al. · The Journal of Infectious Diseases · 2018 · 305 citations · Full text

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Ira M. Jacobson, Eric Lawitz, Edward Gane et al. · Gastroenterology · 2017 · 236 citations · Full text

, , +10

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

Jordan J. Feld, Christopher Kandel, Mia J. Biondi et al. · The Lancet Respiratory Medicine · 2021 · 235 citations · Full text

Reduced Virulence of Group A Streptococcal Tn <i>916</i> Mutants That Do Not Produce Streptolysin S

Stephen Betschel, Sergio Borgia, Neil L. Barg et al. · Infection and Immunity · 1998 · 141 citations · Full text

Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

Sergio Borgia, Janet Dearden, Eric M. Yoshida et al. · Journal of Hepatology · 2019 · 122 citations · Full text

Rows per page

1–5 of 23